12-19-17 5:15 AM EST | Email Article

By Oliver Griffin


PureTech Health PLC (PRTC.LN) said Tuesday that affiliate company Entrega will receive $5 million after entering a research-collaboration agreement with Eli Lilly & Co. (LLY).

Entrega will receive the sum in equity and research funding from Eli Lilly, allowing it to investigate the application of its peptide-delivery technology to Eli Lilly products and therapeutic candidates, PureTech said.

The agreement does not grant Eli Lilly a development or commercialization license for the Entrega technology, PureTech added.

Shares in PureTech Health at 0949 GMT were up 4%, or 5 pence, at 145.00 pence.


Write to Oliver Griffin at oliver.griffin@dowjones.com


(END) Dow Jones Newswires

December 19, 2017 05:15 ET (10:15 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Add a Comment

Try Premium Membership today. Your first 14 days are free of charge. Start my Premium Membership Trial.
Sponsored Links
Buy a Link Now
Sponsor Center
Content Partners